Who owns Intuitive Surgical's stock?
Intuitive Surgical's stock is owned by a variety of retail and institutional investors.
What are analysts'target price targets for Intuitive Surgical's stock?
17 analysts have issued 12-month price objectives for Intuitive Surgical's shares. Their forecasts range from $290.00 to $363.33. On average, they expect Intuitive Surgical's stock price to reach $330.62 in the next twelve months. This suggests a possible upside of 24.3% from the stock's current price.
When is Intuitive Surgical's next quarterly earnings release?
Intuitive Surgical is scheduled to release its next quarterly earnings announcement on Tuesday, April 19th 2022. View our earnings forecast for Intuitive Surgical.
How does Intuitive Surgical's media sentiment compare to other medical stocks?
Intuitive Surgical earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave news coverage about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future.
See more
Is Intuitive Surgical a good stock to buy?
Analysts, on average, see it as having an upside of 15% in the next 12 months. Considering that Intuitive is trading more than 20% below its 52-week high of $369.69 per share, it looks like the right time to buy this healthcare stock. Intuitive has the potential to outperform the market in the longer run.
Is Intuitive Surgical publicly traded?
Intuitive Surgical shares (ISRG) are listed on the NASDAQ and all prices are listed in US Dollars.
Does Intuitive Surgical stock pay dividends?
Intuitive Surgical's profit base is quite significant and growing. But for income-focused investors, Intuitive Surgical may not be the right choice. After all, the company has never paid a dividend.
How many times has Intuitive Surgical stock split?
According to our Intuitive Surgical stock split history records, Intuitive Surgical has had 2 splits.
Is Intuitive Surgical a Fortune 500?
Intuitive Surgical | 2022 Fortune 500 | Fortune.
Is Isrg overvalued?
Summary. ISRG' has a weak valuation at its current share price on account of a overvalued PEG ratio due to strong growth. ISRG's PE and PEG are worse than the market average leading to a below average valuation score. Click Here to get the full Report on Intuitive Surgical, Inc.
Why did Intuitive Surgical stock drop?
Why? Because management gave out weak guidance on the Q1 conference call. According to the executive team, patients are still delaying elective surgeries (which Intuitive Surgical specializes in) around the globe because of the COVID-19 pandemic.
Should I buy ISRG Zacks?
The financial health and growth prospects of ISRG, demonstrate its potential to underperform the market. It currently has a Growth Score of D. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B.
What was Tesla stock split?
If you're looking to buy Tesla stock or already invest in the company, take note that share prices could plummet in the near future. That's because the electric carmaker announced a 3-for-1 stock split in its latest regulatory filing. Tesla will ask its investors to approve the split at its annual meeting in August.
Should I buy or sell Intuitive Surgical stock right now?
18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Intuitive Surgical in the last twelve months. There are...
What is Intuitive Surgical's stock price forecast for 2022?
18 brokers have issued twelve-month price targets for Intuitive Surgical's shares. Their forecasts range from $280.00 to $363.33. On average, they...
How has Intuitive Surgical's stock price performed in 2022?
Intuitive Surgical's stock was trading at $359.30 at the beginning of 2022. Since then, ISRG stock has decreased by 42.9% and is now trading at $20...
When is Intuitive Surgical's next earnings date?
Intuitive Surgical is scheduled to release its next quarterly earnings announcement on Tuesday, July 19th 2022. View our earnings forecast for Int...
How were Intuitive Surgical's earnings last quarter?
Intuitive Surgical, Inc. (NASDAQ:ISRG) posted its quarterly earnings data on Thursday, April, 21st. The medical equipment provider reported $1.00 e...
When did Intuitive Surgical's stock split? How did Intuitive Surgical's stock split work?
Intuitive Surgical's stock split on Tuesday, October 5th 2021. The 3-1 split was announced on Thursday, August 5th 2021. The newly issued shares we...
Who are Intuitive Surgical's key executives?
Intuitive Surgical's management team includes the following people: Dr. Gary S. Guthart Ph.D. , Pres, CEO & Director (Age 56, Pay $2.22M) Mr. Ma...
What is Gary S. Guthart's approval rating as Intuitive Surgical's CEO?
431 employees have rated Intuitive Surgical CEO Gary S. Guthart on Glassdoor.com . Gary S. Guthart has an approval rating of 99% among Intuitive S...
Who are some of Intuitive Surgical's key competitors?
Some companies that are related to Intuitive Surgical include Abbott Laboratories (ABT) , Medtronic (MDT) , Stryker (SYK) , Becton, Dickinson a...
Is Intuitive Surgical stock a Buy, Sell or Hold?
Intuitive Surgical stock has received a consensus rating of buy. The average rating score is and is based on 31 buy ratings, 26 hold ratings, and 0...
What was the 52-week low for Intuitive Surgical stock?
The low in the last 52 weeks of Intuitive Surgical stock was 206.66. According to the current price, Intuitive Surgical is 106.34% away from the 52...
What was the 52-week high for Intuitive Surgical stock?
The high in the last 52 weeks of Intuitive Surgical stock was 369.69. According to the current price, Intuitive Surgical is 59.44% away from the 52...
What are analysts forecasts for Intuitive Surgical stock?
The 57 analysts offering price forecasts for Intuitive Surgical have a median target of 652.72, with a high estimate of 1,100.00 and a low estimate...
About Intuitive Surgical
Headlines
Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G.
How much did intuitive surgical make in 2017?
Could The Intuitive Surgical, Inc. (NASDAQ:ISRG) Ownership Structure Tell Us Something Useful?
What is intuitive surgical?
For the fiscal year 2017, Intuitive Surgical reported earnings of US$660 million, with an annual revenue of US$3.129 billion, an increase of 15.7% over the previous fiscal cycle. Intuitive Surgical's shares traded at over $307 per share, and its market capitalization was valued at over US$58 billion in November 2018.
What was the name of the da Vinci surgical system?
is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the NASDAQ-100 and S&P 500. As of December 31, 2019, Intuitive Surgical had an installed base of 5,582 da Vinci Surgical Systems, including 3,531 in the U.S., 977 in Europe, 780 in Asia, and 294 in the rest of the world.
How much does a da Vinci system cost?
One was named "Leonardo", and another was "Mona". The final version of the prototype was nicknamed the da Vinci Surgical System, and the name stuck when the system was eventually commercialized. After further testing, Intuitive Surgical began marketing this system in Europe in 1999, while awaiting FDA approval in the United States.
What is the name of the SRI system?
A da Vinci Surgical System costs approximately $1.5 million. The new da Vinci SI released in April 2009 cost about $1.75 million.
When was the Da Vinci surgical system invented?
The company refined the SRI System into a prototype known originally as "Lenny" (after the young Leonardo da Vinci), which was ready for testing in 1997. As the company's prototypes became more advanced, they were named using da Vinci themes. One was named "Leonardo", and another was "Mona".
When was the prostate system approved?
The research that eventually led to the development of the da Vinci Surgical System was performed in the late 1980s at a non-profit research institute SRI International. In 1990, SRI received funding from the National Institutes of Health. SRI developed a prototype robotic surgical system that caught the interest of the Defense Advanced Research ...
